Central nervous system infections in the critically ill

Journal of Pharmacy Practice

Volumn 18, Issue 1, 2005, Pages 25-41

  Lewin III, John J ^a,b   Lapointe, Marc ^c,d   Ziai, Wendy C ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Abscess; Encephalitis; Meningitis; Subdural empyema; Ventriculitis

Indexed keywords

AMPICILLIN; AMPICILLIN PLUS CEFOTAXIME PLUS VANCOMYCIN; AMPICILLIN PLUS CEFTRIAXONE PLUS VANCOMYCIN; AMPICILLIN PLUS GATIFLOXACIN PLUS VANCOMYCIN; AMPICILLIN PLUS GENTAMICIN; AMPICILLIN PLUS MEROPENEM PLUS VANCOMYCIN; ANTIINFECTIVE AGENT; CEFEPIME; CEFOTAXIME; CEFOTAXIME PLUS VANCOMYCIN; CEFTRIAXONE; CEFTRIAXONE PLUS VANCOMYCIN; CHLORAMPHENICOL; CHLORAMPHENICOL PLUS VANCOMYCIN; GATIFLOXACIN; GATIFLOXACIN PLUS TRIMETHOPRIM PLUS VANCOMYCIN; GENTAMICIN; LINEZOLID; MEROPENEM; MEROPENEM PLUS TRIMETHOPRIM PLUS VANCOMYCIN; MEROPENEM PLUS VANCOMYCIN; NAFCILLIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXACILLIN; PENICILLIN G; RIFAMPICIN; RIFAMPICIN PLUS VANCOMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BLOOD CLOTTING; BRAIN ABSCESS; BRAIN INFARCTION; BRAIN VENTRICULITIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHRONIC MENINGITIS; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; EMPYEMA; ENCEPHALITIS; EPIDURAL ABSCESS; HEAD INJURY; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE; MENINGITIS; MENINX; NEUROIMAGING; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; REVIEW; SEIZURE; SEPTIC SHOCK; SHUNT INFECTION; STROKE; SUBDURAL EMPYEMA; VASCULITIS; VEIN THROMBOSIS;

EID: 12844271057     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/0897190004273604     Document Type: Review

References (147)

1. Segreti J, Harris AA. Acute bacterial meningitis. Infect Dis Clin North Am. 1996;10:797-809.
2. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med. 1993;328:21-28.
3. Lapointe M, Haines SJ, Landesman S. Basic principles of antimicrobial therapy of CNS infections. In: Cooper PR, Golfinos JG, eds. Head Injury. Vol 1, 4th ed. New York, NY: McGraw-Hill; 2000:483-498.
4. Bleck TP, Greenlee JE. Approach to the patient with central nervous system infection. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Vol 1, 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:950-960.
5. Tofte RW, Peterson PK, Kim Y. Opsonic activity in normal human cerebrospinal fluid for selected bacterial species. Infect Immun. 1979;26:1093-1098.
6. Thea D, Barza M. Use of antibacterial agents in infections of the central nervous system. Infect Dis Clin North Am. 1989;3:553-570.
7. Grant GA, Janigro D. The blood-brain barrier. In: Youmans JR, Becker DP, eds. Youmans Neurological Surgery. Vol 1, 5th ed. Philadelphia, Pa: Saunders; 2004:153-159.
8. Ristuccia AM, LeFrock JL. Cerebrospinal fluid penetration of antimicrobials. Antimicrob Agents Chemother. 1992;45:118-152.
9. Selkow JB, Barling RW. The cerebrospinal fluid penetration of antibiotics. J Antimicrob Ther. 1978;4:204-227.
10. Kearney BP, Aweeka FT. The penetration of anti-infectives into the central nervous system. Neurol Clin. 1999;17:883-900.
11. Scheld WM. Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system. Rev Infect Dis. 1989;11(suppl 7):S1669-1690.
12. Coant PN, Kornberg AE, Duffy LC, Dryja DM, Hassan SM. Blood culture results as determinants in the organism identification of bacterial meningitis. Pediatr Emerg Care. 1992;8:200-205.
13. Roos K, Tunkel AR, Scheld WM. Acute bacterial meningitis in children and adults. In: Scheld W, Whitley R, Durack D, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1997:335-402.
14. Coyle PK. Overview of acute and chronic meningitis. Neurol Clin. 1999;17:691-710.
15. Wijdicks E. Acute bacterial infections of the central nervous system. In: Wijdicks E, ed. Neurologic Catastrophes in the Emergency Department. Boston, Mass: Butterworth Heinemann; 2000:183-194.
16. Armstrong W, Boulis N, McGillicuddy I. Infections of the central nervous system. In: Crockard H, Hoff J, eds. Neurosurgery: The Scientific Basis of Clinical Practice. Vol 2, 3rd ed. Oxford, UK: Blackwell Science; 2000:757-783.
17. Kaplan SL, Smith EO, Wills C, Feigin RD. Association between preadmission oral antibiotic therapy and cerebrospinal fluid findings and sequelae caused by Haemophilus influenzae type b meningitis. Pediatr Infect Dis. 1986;5:626-632.
18. Koskiniemi M, Piiparinen H, Mannonen L, Rantalaiho T, Vaheri A. Herpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. The Study Group. J Neurol Neurosurg Psychiatry. 1996;60:174-178.
19. Zimmerman R, Girard N. Imaging of intracranial infections. In: Scheld W, Durack D, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1997.
20. Davis JM, Davis KR, Kleinman GM, Kirchner HS, Taveras JM. Computed tomography of herpes simplex encephalitis, with clinicopathological correlation. Radiology. 1978;129:409-417.
21. Zimmerman R, Weingarten K. Neuroimaging of cerebral abscesses. Neuroimaging Clin N Am. 1991;1:1-16.
22. Wispelwey B, Dacey R, Scheld W. Brain abscess. In: Scheld W, Whitley R, Durack D, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1997:463-493.
23. Rehncrona S, Brismar J, Holtas S. Diagnosis of brain abscesses with indium-111-labeled leukocytes. Neurosurgery. 1985;16:23-26.
24. Grimstad IA, Hirschberg H, Rootwelt K. 99mTc-hexamethylpropyleneamine oxime leukocyte scintigraphy and C-reactive protein levels in the differential diagnosis of brain abscesses. J Neurosurg. 1992;77:732-736.
25. Smith JB, Westmoreland BF, Reagan TJ, Sandok BA. A distinctive clinical EEG profile in herpes simplex encephalitis. Mayo Clin Proc. 1975;50:469-474.
26. Roos KL. Encephalitis. Neurol Clin. 1999;17:813-833.
27. Anderson NE, Willoughby EW. Chronic meningitis without predisposing illness: a review of 83 cases. Q J Med. 1987;63:283-295.
28. Connolly KJ, Hammer SM. The acute aseptic meningitis syndrome. Infect Dis Clin North Am. 1990;4:599-622.
29. Townsend GC, Scheld WM. Infections of the central nervous system. Adv Intern Med. 1998;43:403-447.
30. Rotbart HA. Enteroviral infections of the central nervous system. Clin Infect Dis. 1995;20:971-981.
31. Hammer SM, Connolly KJ. Viral aseptic meningitis in the United States: clinical features, viral etiologies, and differential diagnosis. Curr Clin Top Infect Dis. 1992;12:1-25.
32. Hollander H, Stringari S. Human immunodeficiency virus-associated meningitis: clinical course and correlations. Am J Med. 1987;83:813-816.
33. Prevalence of penicillin-resistant Streptococcus pneumoniae: Connecticut, United States, 1992-1993. Can Commun Dis Rep. 1994;20:71-73.
34. Maxson S, Jacobs RF. Viral meningitis: tips to rapidly diagnose treatable causes. Postgrad Med. 1993;93:153-156, 159-160, 163-166.
35. Rubeiz H, Roos RP. Viral meningitis and encephalitis. Semin Neurol. 1992;12:165-177.
36. Johnson R. Meningitis, encephalitis, and poliomyelitis. In: Viral Infections of the Central Nervous System. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1998:87-132.
37. Tunkel AR, Scheld WM. Acute meningitis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. Vol 1, 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:959-997.
38. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med. 1997;336:708-716.
39. Kernig V. Ueber ein Krankheits Symptom der acuten Meningitis. St Petersberg Med Wochenschr. 1882;7:398.
40. Brudzinski J. Un signe nouveau sur les membres inferieurs dans les meningites chez les infants (signe de la nuque). Arch Med Enfants. 1909;12:745-752.
41. Pfister HW, Feiden W, Einhaupl KM. Spectrum of complications during bacterial meningitis in adults: results of a prospective clinical study. Arch Neurol. 1993;50:575-581.
42. Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S. Acute bacterial meningitis in adults: a 20-year overview. Arch Intern Med. 1997;157:425-430.
43. Hussein AS, Shafran SD. Acute bacterial meningitis in adults: a 12-year review. Medicine (Baltimore). 2000;79:360-368.
44. Igarashi M, Gilmartin RC, Gerald B, Wilburn F, Jabbour JT. Cerebral arteritis and bacterial meningitis. Arch Neurol. 1984;41:531-535.
45. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129:862-869.
46. Lu CH, Huang CR, Chang WN, et al. Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. Clin Neurol Neurosurg. 2002;104:352-358.
47. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J. 1992;11:694-698.
48. Talan DA, Zibulewsky J. Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med. 1993;22:1733-1738.
49. Schlech WF III, Ward JI, Band JD, Hightower A, Fraser DW, Broome CV. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985;253:1749-1754.
50. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990;162:1316-1323.
51. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997;337:970-976.
52. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-1284.
53. Doern GV, Brueggemann AB, Huynh H, Wingert E. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98. Emerg Infect Dis. 1999;5:757-765.
54. Doern GV. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis. 2001;33(suppl 3):S187-192.
55. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N Engl J Med. 1988;319:964-971.
56. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988. JAMA. 1997;278:925-931.
57. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991;324:1525-1531.
58. Coyle PK. Glucocorticoids in central nervous system bacterial infection. Arch Neurol. 1999;56:796-801.
59. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347:1549-1556.
60. Ahmed A, Jafri H, Lutsar I, et al. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1999;43:876-881.
61. Thomas R, Le Tulzo Y, Bouget J, et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Med. 1999;25:475-480.
62. Geraci JE, Heilman FR, Nichols DR, Wellman EW, Ross GT. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Antibiot Annu. 1956:90-106.
63. Nau R, Sorgel F, Prange HW. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet. 1998;35:223-246.
64. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991;35:2467-2472.
65. Tunkel AR, Scheld WM. Corticosteroids for everyone with meningitis? N Engl J Med. 2002;347:1613-1615.
66. Davis LE, Greenlee JE. Pneumococcal meningitis: antibiotics essential but insufficient. Brain. 2003;126(pt 5):1013-1014.
67. Cohen J. Management of bacterial meningitis in adults. BMJ. 2003;326:996-997.
68. van der Flier M, Geelen SP, Kimpen JL, Hoepelman IM, Tuomanen EI. Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin Microbiol Rev. 2003;16:415-429.
69. Friedland IR, Paris M, Ehrett S, Hickey S, Olsen K, McCracken GH Jr. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1993;37:1630-1636.
70. Martinez-Lacasa J, Cabellos C, Martos A, et al. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J Antimicrob Chemother. 2002;49:507-513.
71. Swartz MN. "Chronic meningitis": many causes to consider. N Engl J Med. 1987;317:957-959.
72. Hildebrand J, Aoun M. Chronic meningitis: still a diagnostic challenge. J Neurol. 2003;250:653-660.
73. Udani PM, Parekh UC, Dastur DK. Neurological and related syndromes in CNS tuberculosis: clinical features and pathogenesis. J Neurol Sci. 1971;14:341-357.
74. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med. 1992;326:668-672.
75. Humphries M. The management of tuberculous meningitis. Thorax. 1992;47:577-581.
76. Garcia-Monco JC. Central nervous system tuberculosis. Neurol Clin. 1999;17:737-759.
77. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603-662.
78. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741-1751.
79. Bordon J, Martinez-Vazquez C, Alvarez M, et al. Neurosyphilis in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 1995;14:864-869.
80. Funnye AS, Akhtar AJ. Syphilis and human immunodeficiency virus co-infection. J Natl Med Assoc. 2003;95:363-382.
81. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 2002;51(RR-6):1-78.
82. Davis LE. Fungal infections of the central nervous system. Neurol Clin. 1999;17:761-781.
83. Stamm AM, Diasio RB, Dismukes WE, et al. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med. 1987;83:236-242.
84. Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother. 2000;46:171-179.
85. Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis. 1998;26:1383-1396.
86. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis. 1998;27:603-618.
87. Leenders AC, Reiss P, Portegies P, et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS. 1997;11:1463-1471.
88. Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis. 2000;182:274-282.
89. Hajdu R, Thompson R, Sundelof JG, et al. Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrob Agents Chemother. 1997;41:2339-2344.
90. Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother. 2004;54:292-294.
91. Patel R. Antifungal agents. Part I: Amphotericin B preparations and flucytosine. Mayo Clin Proc. 1998;73:1205-1225.
92. Arthur RR, Drew RH, Perfect JR. Novel modes of antifungal drug administration. Expert Opin Investig Drugs. 2004;13:903-932.
93. Chretien F, Belec L, Hilton DA, et al. Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol. 1996;22:394-404.
94. Hamilton RL, Achim C, Grafe MR, Fremont JC, Miners D, Wiley CA. Herpes simplex virus brainstem encephalitis in an AIDS patient. Clin Neuropathol. 1995;14:45-50.
95. Bertram M, Schwarz S, Hacke W. Acute and critical care in neurology. Eur Neurol. 1997;38:155-166.
96. Johnson RT. Acute encephalitis. Clin Infect Dis. 1996;23:219-224.
97. Schmutzhard E. Viral infections of the CNS with special emphasis on herpes simplex infections. J Neuril. 2001;248:469-477.
98. McGrath N, Anderson NE, Croxson MC, Powell KF. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997;63:321-326.
99. Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002;359:507-513.
100. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314:144-149.
101. Chaudhuri A, Kennedy PG. Diagnosis and treatment of viral encephalitis. Postgrad Med J. 2002;78:575-583.
102. Anduze-Faris BM, Fillet AM, Gozlan J, et al. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS. 2000;14:517-524.
103. Balfour HH Jr. Antiviral drugs. N Engl J Med. 1999;340:1255-1268.
104. Sagher O. Surgical management of CNS infections. In: Scheld W, Whitley R, Durack D, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1997:945-972.
105. Tenney JH. Bacterial infections of the central nervous system in neurosurgery. Neurol Clin. 1986;4:91-114.
106. Calfee DP, Wispelwey B. Brain abscess. Semin Neurol. 2000;20:353-360.
107. Seydoux C, Francioli P. Bacterial brain abscesses: factors influencing mortality and sequelae. Clin Infect Dis. 1992;15:394-401.
108. Sofianou D, Selviarides P, Sofianos E, Tsakris A, Foroglou G. Etiological agents and predisposing factors of intracranial abscesses in a Greek university hospital. Infection. 1996;24:144-146.
109. Pruitt AA. Infections of the nervous system. Neurol Clin. 1998;16:419-447.
110. Ziai WC, Geocadin RG. Central nervous system infections: a critical care approach. Curr Neurol Neurosci Rep. 2001;1:577-586.
111. Bleck T, Greenlee J. Epidural abscess. In: Mandell G, Bennett J, Donlin R, eds. Principles and Practice of Infectious Diseases. Vol 1, 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:1031-1034.
112. Rigamonti D, Liem L, Sampath P, et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol. 1999;52:189-196.
113. Nussbaum ES, Rigamonti D, Standiford H, Numaguchi Y, Wolf AL, Robinson WL. Spinal epidural abscess: a report of 40 cases and review. Surg Neurol. 1992;38:225-231.
114. Bleck T, Greenlee J. Subdural empyema. In: Mandell G, Bennett J, Donlin R, eds. Principles and Practice of Infectious Diseases. Vol 1, 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:1028-1031.
115. Salmon JH. Ventriculitis complicating meningitis. Am J Dis Child. 1972;124:35-40.
116. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy- related infections: a critical review of the literature. Neurosurgery. 2002;51:170-181.
117. Lyke KE, Obasanjo OO, Williams MA, O'Brien M, Chotani R, Perl TM. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis. 2001;33:2028-2033.
118. The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Br J Neurosurg. 2000;14:7-12.
119. Holloway KL, Barnes T, Choi S, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg. 1996;85:419-424.
120. Rebuck JA, Murry KR, Rhoney DH, Michael DB, Coplin WM. Infection related to intracranial pressure monitors in adults: analysis of risk factors and antibiotic prophylaxis. J Neurol Neurosurg Psychiatry. 2000;69:381-384.
121. Pfausler B, Spiss H, Beer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg. 2003;98:1040-1044.
122. Luer MS, Hatton J. Vancomycin administration into the cerebrospinal fluid: a review. Ann Pharmacother. 1993;27:912-921.
123. Bayston R, Hart CA, Barnicoat M. Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatry. 1987;50:1419-1423.
124. Pfausler B, Haring HP, Kampfl A, Wissel J, Schober M, Schmutzhard E. Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage. Clin Infect Dis. 1997;25:733-735.
125. Reesor C, Chow AW, Kureishi A, Jewesson PJ. Kinetics of intraventricular vancomycin in infections of cerebrospinal fluid shunts. J Infect Dis. 1988;158:1142-1143.
126. Kay EA, Sanders PJ, Slesenger JP, Bailie GR. Disposition of intrathecal vancomycin. Drug Intell Clin Pharm. 1988;22:267-268.
127. Hirsch BE, Amodio M, Einzig AI, Halevy R, Soeiro R. Instillation of vancomycin into a cerebrospinal fluid reservoir to clear infection: pharmacokinetic considerations. J Infect Dis. 1991;163:197-200.
128. Nagl M, Neher C, Hager J, Pfausler B, Schmutzhard E, Allerberger F. Bactericidal activity of vancomycin in cerebrospinal fluid. Antimicrob Agents Chemother. 1999;43:1932-1934.
129. Wen DY, Bottini AG, Hall WA, Haines SJ. Infections in neurologic surgery: the intraventricular use of antibiotics. Neurosurg Clin N Am. 1992;3:343-354.
130. Wright PF, Kaiser AB, Bowman CM, McKee KT Jr, Trujillo H, McGee ZA. The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis. J Infect Dis. 1981;143:141-147.
131. McCracken GH Jr, Mize SG, Threlkeld N. Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet. 1980;1:787-791.
132. Wald SL, McLaurin RL. Cerebrospinal fluid antibiotic levels during treatment of shunt infections. J Neurosurg. 1980;52:41-46.
133. Preston SL, Briceland LL. Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli. Ann Pharmacother. 1993;27:870-873.
134. Haase KK, Lapointe M, Haines SJ. Aseptic meningitis after intraventricular administration of gentamicin. Pharmacotherapy. 2001;21:103-107.
135. Gilbert VE, Beals JD Jr, Natelson SE, Tyler WA. Treatment of cerebrospinal fluid leaks and gram-negative bacillary meningitis with large doses of intrathecal amikacin and systemic antibiotics. Neurosurgery. 1986;18:402-406.
136. Hamory B, Ignatiadis P, Sande MA. Intrathecal amikacin administration: use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis. JAMA. 1976;236:1973-1974.
137. Wirt TC, McGee ZA, Oldfield EH, Meacham WF. Intraventricular administration of amikacin for complicated gram-negative meningitis and ventriculitis. J Neurosurg. 1979;50:95-99.
138. Ross GH, Gunderson BW, Ibrahim KH, Sullivan CJ, Rotschafer JC. Central nervous system infections. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophyslologic Approach. 5th ed. New York, NY: McGraw-Hill; 2002:1831-1847.
139. Nettis E, Calogiuri G, Colanardi MC, Ferrannini A, Tursi A. Drug-induced aseptic meningitis. Curr Drug Targets Immune Endocr Metabol Disord. 2003;3:143-149.
140. Capra C, Monza GM, Meazza G, Ramella G. Trimethoprimsulfamethoxazole- induced aseptic meningitis: case report and literature review. Intensive Care Med. 2000;26:212-214.
141. Carlson J, Wiholm BE. Trimethoprim associated aseptic meningitis. Scand J Infect Dis. 1987;19:687-691.
142. Jolles S, Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf. 2000;22:215-226.
143. Marinac JS. Drug- and chemical-induced aseptic meningitis: a review of the literature. Ann Pharmacother. 1992;26:813-822.
144. De Marcaida JA, Reik L Jr. Disorders that mimic central nervous system infections. Neurol Clin. 1999;17:901-941.
145. Schlipkoter U, Muhlberger N, von Kries R, Weil J. Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany. Infection. 2002;30:351-355.
146. Spach DH. New issues in bacterial meningitis in adults: antibiotic resistance has complicated treatment. Postgrad Med. 2003;114:43-50.
147. Spach DH, Jackson LA. Bacterial meningitis. Neurol Clin. 1999;17:711-735.